{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-21-004665","form_type":"8-K","ticker":"AGTX","cik":"0001603345","company_name":"Agentix Corp.","filed_at":"2021-07-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.764793+00:00","generated_at":"2026-06-30T04:50:03.455264+00:00","sec_items":["2.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Agentix Corp. completes merger with Applied Biopharma LLC; interests converted to common stock","bullets":["Merger completed July 14, 2021: AB Merger LLC merged into Applied Biopharma, with Applied Biopharma surviving.","Each Applied Biopharma LLC interest was converted into one share of Agentix common stock ($0.001 par).","Articles of Merger filed with Nevada Secretary of State on July 14, 2021.","Merger Agreement dated July 13, 2021, previously filed as Exhibit 2.1 to a July 14, 2021 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-21-004665","json":"https://secwatch.observer/filing/0001477932-21-004665.json","markdown":"https://secwatch.observer/filing/0001477932-21-004665.md","text":"https://secwatch.observer/filing/0001477932-21-004665.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1603345/000147793221004665/0001477932-21-004665-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1603345/000147793221004665/agtx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T04:50:03.455264+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}